Skip to main content
Premium Trial:

Request an Annual Quote

Dick Syron, Gerald Vardzel, George Grills, Cepheid

Premium

Pairings

Genzyme announced this week that Dick Syron has joined its board of directors.

Syron is CEO and chairman of Freddie Mac. Previously, he has served as CEO, president and chairman of the board at Thermo Electron. He was chairman of the American Stock Exchange from 1994 — 1999.


Gene Express named Gerald Vardzel CEO last week. He was also appointed assistant to chairman of the board.

Vardzel was previously vice president of business development at the company. Prior to Gene Express, he held several key management positions at Becton Dickinson. He has also been a consultant for small- to mid-size equity firms. He is a director for JKMP Group.


George Grills has taken the position of director of advanced technology assessment at Cornell University Institute for Biotechnology and Life Science Technology.

Grills was formerly director of DNA sequencing at Harvard-Partners Genome Center.

 

New Releases

Cepheid last week launched its GeneXpert System for in vitro diagnostic use and its Xpert BCR-ABL Monitor assay, which runs on the GeneXpert platform, in the European market. Both GeneXpert and the Xpert BCR-ABL Monitor were released as "Conformite Europeene" (CE) IVD Mark products under the European Directive on In Vitro Diagnostic Medical Devices, the company said in a statement.

The Xpert BCR-ABL Monitor is intended for use in the quantitative monitoring of the BCR-ABL levels of chronic myelogenous leukemia patients to identify those who might be beginning to show resistance to treatment, and in monitoring patients for minimal residual disease. The assay allows healthcare providers in Europe to obtain "timely, near-patient, highly sensitive and accurate results from a blood sample, with minimal potential for RNA loss or sample contamination," Cepheid said. The system purifies, concentrates, detects and identifies targeted nucleic acid sequences, and the BCR-ABL assay provides results in approximately two hours, compared to two to three days for most similar procedures in reference laboratories, the company added.

Filed under

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more